Serum leptin concentrations in a normal population and in GH deficiency: Negative correlation with testosterone in men and effects of GH treatment

Clinical Endocrinology

Volumn 47, Issue 2, 1997, Pages 191-198

  Nyström, Fredrik ^a   Ekman, Bertil ^a   Österlund, Maria ^a   Lindström, Torbjörn ^a   Öhman, K Peter ^a   Arnqvist, Hans J ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; LEPTIN; NEUROPEPTIDE Y; SOMATOMEDIN C; TESTOSTERONE;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE DETERMINATION; HUMAN; IMMUNOASSAY; MALE; METABOLISM; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

EID: 0030742514     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.2281039.x     Document Type: Article

References (23)

1. Considine, R.V., Sinha, M.K., Heiman, M.L., Kriaciunas, A., Stephens, T.W., Nyce, M.R., Ohannesian, J.P., Margo, C.C., McKee, L.J., Bauer, T.L. & Caro, J.F. (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. The New England Journal of Medicine, 334, 292-295.
2. Erickson, J.C., Clegg, K.E. & Palmiter, R.D. (1996) Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature, 381, 415-418.
3. Fernlund, P., Gershagen, S., Larsson, I. & Rannevik, G. (1985) Radioimmunoassay of human sex hormone binding globulin: improved radioiodination procedure. Scandinavian Journal of Clinical and Laboratory Investigation, 45, 461-469.
4. Forbes, C.B., Porta, C.R., Herr, B.E. & Griggs, R.C. (1992) Sequence of changes in body composition induced by testosterone and reversal of changes after drug is stopped. Journal of the American Medical Association, 267, 397-399.
5. Friedewald, W.T., Levy, R.I. & Fredrickson, D.S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry, 18, 499-502.
6. Glauser, S.C., Glauser, E.M., Reidenberg, M.M., Rusy, B.E. & Tallarida, R.S. (1970) Metabolic changes associated with cessation of cigarette smoking. Archives of Environmental Health, 20, 377-381.
7. Heilig, M. & Ekman, R. (1995) Chronic parenteral antidepressant treatment in rats: unaltered levels and processing on neuropeptide Y (NPY) and corticotropin-releasing hormone (CRH). Neurochemistry International, 26, 351-355.
8. Jones, J.I. & Clemmons, D.R. (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocrine Reviews, 16, 3-34.
9. Jorgensen, J.O.L., Pedersen, S.A., Thuesen, L., Jorgensen, J., Ingemann-Hansen, T., Skakkebaek, N.E. & Christiansen, J.S. (1989) Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet, 1, 1221-1225.
10. Kolacynski, J.K., Nyce, M.E., Considine, R.V., Boden, G., Nolan, J.J., Henry, R., Mudalair, S.R., Olefsky, J. & Caro, J.F. (1996) Acute and chronic effect of insulin on leptin production in vivo and in vitro. Diabetes, 45, 699-701.
11. Lee, M.C., Schiffman, S.S. & Pappas, T.N. (1994) Role of neuropeptides in the regulation of feeding behavior: a review of cholecystokinin, bombesin, neuropeptide Y, and galanin. Neuroscience and Biobehavioral Reviews, 18, 313-323.
12. Lindström, T., Arnqvist, H., Ludvigsson, J. & von Schenck, H. (1992) C-peptide profiles in patients with non-insulin-dependent diabetes mellitus before and during insulin treatment. Acta Endocrinologica, 126, 477-483.
13. Maffei, M., Halaas, J., Ravussin, E., Pratley, R.E., Lee, G.H., Zhang, Y., Fei, H., Lallone, R., Ranganathan, S., Kern, P.A. & Friedman, J.M. (1995) Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Medicine, 11, 1155-1161.
14. Plymate, S.R., Matej, L.A., Jones, R.E. & Friedl, K.E. (1988) Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. Journal of Clinical Endocrinology and Metabolism, 67, 460-464.
15. Reaven, G. (1988) Role of insulin resistance in human disease. Diabetes, 37, 1595-1607.
16. Saladin, R., de Vos, P., Guerre-Millo, M., Leturque, A., Girard, J., Staels, B. & Auwerx, J. (1995) Transient increase in obese gene expression after food intake or insulin administration. Nature, 377, 527-529.
17. Salomon, F., Cimep, R.C., Hesp, R. & Sönksen, P.H. (1989) The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New England Journal of Medicine, 321, 1797-1803.
18. Schwartz, M.W., Baskin, D.G., Bukowski, T.R., Kuijper, J.L., Foster, D., Lasser, G., Porte, D., Woods, S.C., Seeley, R.J. & Weigle, D.S. (1996) Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes, 45, 531-535.
19. Soini, E. & Kojola, H. (1983) Time-resolved fluorometer for lanthanide chelates - a new generation of nonisotopic immunoassays. Clinical Chemistry, 29, 65-68.
20. Stephens, T.W., Basinski, M., Bristow, P.K., Bue-Valleskey, J.M., Burgett, S.G., Craft, L., Hale, J., Hoffmann, J., Hsiung, H.M., Kriauciunas, A., MacKellar, W., Rosteck, P.R., Schoner, B., Smith, D., Tinsley, F.C., Zhang, X.-Y. & Heiman, M. (1995) The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature, 377, 530-532.
21. Wack, J.T. & Rodin, J. (1982) Smoking and its effects on body weight and the systems of caloric regulation. American Journal of Clinical Nutrition, 35, 366-380.
22. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L. & Friedman, J.M. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature, 372, 425-432.
23. Zukowska-Grojec, Z. & Wahlestedt, C. (1993) Origins and actions of neuropeptide Y in the cardiovascular system. In The Biology of Neuropeptide Y and Related Pepties (ed. W.F. Colmers & C. Wahlestedt), pp. 315-388. Humana Press, New Jersey.